Amgen's Attempt to Control Nature Under Scrutiny.

The Supreme Court will hear oral arguments in Amgen v. Sanofi, a case that could have immense consequences for scientific innovation. If the overbroad patents at issue are upheld, it could allow early inventors to monopolize entire fields of future scientific endeavor, creating barriers to innovation and depriving doctors and patients of medical treatments. A balanced patent system that rewards new inventions while leaving undiscovered territory open for exploration is crucial for scientific progress.